Reproductive Genetics Market Report mainly improves market size,and provide detailed product mapping and investigation of various market scenarios. Our expert analysts provide a thorough analysis and breakdown of the market presence of key market leaders. We strive to stay updated with the recent developments and follow the latest company news related to the industry players operating in the global Reproductive Genetics market. This helps us to comprehensively analyze the individual standing of the companies as well as the competitive landscape. Our vendor landscape analysis offers a complete study to help you gain the upper hand in the competition.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/695
Rise in adoption of genetic tests and advancements in molecular diagnostics is driving global reproductive genetics market revenue growth.Reproductive genetics focus on fertility and reproduction that affect some families in the form of chromosomal and genetic abnormalities that increase risk to biological children, reproductive loss, multiple miscarriages, and family history of genetic abnormalities.
Chromosomal abnormalities are responsible for 50% of miscarriages in first trimester. Reproductive genetics identifies embryos without these abnormalities so that they can be used for IVF, thus increasing the likelihood of healthy pregnancy and baby regardless of patient health. It also helps in achieving higher pregnancy rates per transfer, which reduces the need for IVF and results in low cost, time, and stress.
Segmental Analysis
The global Reproductive Genetics market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the Reproductive Genetics sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.
Single gene disorders are among the most understood genetic disorders due to their inheritance patterns and relatively simple genetic causes. Some of the most common single gene disorders are sickle cell anaemia, hemochromatosis, cystic fibrosis, and Tay-Sachs. Reproductive genetic tests are done to detect the possibility of single gene disorders in babies.
Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.
Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc.
Rapid Business Growth Factors
In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor that’s helping the market grow faster than usual is the tough competition.
Let us know if you have any specific requirements. We offer report customization.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/695
Key Points of Reproductive Genetics Market:
Extensive coverage of the analysis of the Reproductive Genetics market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Reproductive Genetics market
Complete data about the key manufacturers and vendors in the Reproductive Genetics market
Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Laboratory Developed Tests (LDT)
- Kits
- Reagents and Consumables
Procedure Type Outlook (Revenue, USD Billion; 2018–2028)
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
- Carrier Screening
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Next-Generation Sequencing (NGS)
- Microarray
- Polymerase chain reaction (PCR)
- In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018–2028)
- Single Gene Disorder
- Aneuploidy
- Structural Chromosomal Abnormality
- Others
Read More: https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs